Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_007245.4(ATXN2L):c.484G>A(p.Ala162Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,872 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
ATXN2L (HGNC:31326): (ataxin 2 like) This gene encodes an ataxin type 2 related protein of unknown function. This protein is a member of the spinocerebellar ataxia (SCAs) family, which is associated with a complex group of neurodegenerative disorders. Several alternatively spliced transcripts encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The c.484G>A (p.A162T) alteration is located in exon 5 (coding exon 5) of the ATXN2L gene. This alteration results from a G to A substitution at nucleotide position 484, causing the alanine (A) at amino acid position 162 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Gain of phosphorylation at A162 (P = 0.0168);Gain of phosphorylation at A162 (P = 0.0168);Gain of phosphorylation at A162 (P = 0.0168);Gain of phosphorylation at A162 (P = 0.0168);Gain of phosphorylation at A162 (P = 0.0168);Gain of phosphorylation at A162 (P = 0.0168);Gain of phosphorylation at A162 (P = 0.0168);.;.;